Combivent Inhaler Information

Browse eMedTV's wide range of articles related to combivent inhaler information including topics such as combivent and pregnancy, combivent warnings and precautions, and combivent dosage. Use the search box at the top-right corner of the page to find information about other health topics.

Description of Articles in Combivent Inhaler Information

Combivent is typically prescribed to treat chronic obstructive pulmonary disease (COPD). This eMedTV article explains how Combivent works, describes the effects of the medication, and lists potential side effects that can occur.

Headaches, bronchitis, and coughing are among the commonly reported Combivent side effects. This segment from the eMedTV archives also lists serious side effects that may require medical attention, as well as some of the less common side effects.

Combivent is an inhaled drug that is used to treat chronic obstructive pulmonary disease (COPD) in adults. This eMedTV Web page explains Combivent uses in more detail and describes how the medication works to open up the airways to the lungs.

The standard recommended Combivent dosage for treating COPD is two inhalations four times a day. This part of the eMedTV library offers Combivent dosing guidelines and also provides information on when and how to use the inhaler.

If you combine certain medications with Combivent, drug interactions can potentially occur. This eMedTV segment takes an in-depth look at the medications that can cause interactions with Combivent and describes the problems that may occur.

Combivent can cause high blood pressure or an irregular heart rhythm in some people. This eMedTV Web page contains other Combivent warnings and precautions, including other possible complications that may occur during treatment with the drug.

You should seek immediate medical attention if you think you have overdosed on Combivent. This selection from the eMedTV Web site discusses the potential symptoms of a Combivent overdose and describes possible treatment options that are available.

Using Combivent inhalers during pregnancy could potentially harm an unborn child. This eMedTV page discusses the results of animal studies involving Combivent and pregnancy, and explains why the medicine is classified as a pregnancy Category C drug.

It is not known whether Combivent passes through breast milk. This portion of the eMedTV archives explores Combivent and breastfeeding in more detail, explaining why no research has been done on whether the drug passes through breast milk.

This eMedTV resource explains that there is no generic version of Combivent because it is protected by a patent until June 2015. This page also describes some possible circumstances that could delay the production of generic Combivent past 2015.